Search

Clinical Research

Kite Earns Patent for Method to Increase Efficacy of CAR-T

Kite Earns Patent for Method to Increase Efficacy of CAR-T  Genetic Engineering & Biotechnology NewsFull coverage https://www.genengnews.com/gen-exclusives/kite-earns-patent-for-method-to-increase-efficacy-of-car-t/77901032

Advertisements

US FDA accepts Ionis Pharma’s Inotersen NDA for priority review

US FDA accepts Ionis Pharma’s Inotersen NDA for priority review  pharmabiz.comFull coverage http://www.pharmabiz.com/NewsDetails.aspx?aid=106609&sid=2

Pharma giant Pfizer pulls out of research into Alzheimer’s

Pharma giant Pfizer pulls out of research into Alzheimer’s  BBC NewsFull coverage http://www.bbc.co.uk/news/health-42633871

MEI Pharma Announces FDA Clearance of Investigational New Drug Application for CDK Inhibitor Voruciclib

MEI Pharma Announces FDA Clearance of Investigational New Drug Application for CDK Inhibitor Voruciclib  Markets InsiderFull coverage http://markets.businessinsider.com/news/stocks/MEI-Pharma-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-CDK-Inhibitor-Voruciclib-1012665778

FDA signs off on Atara’s IND for MS candidate ATA188

FDA signs off on Atara’s IND for MS candidate ATA188  Investing.comFull coverage https://www.investing.com/news/stock-market-news/fda-signs-off-on-ataras-ind-for-ms-candidate-ata188-1086581

BRIEF-Beigene And Mirati Therapeutics Announce Exclusive License Agreement For Sitravatinib In The Asia Pacific …

BRIEF-Beigene And Mirati Therapeutics Announce Exclusive License Agreement For Sitravatinib In The Asia Pacific …  ReutersFull coverage https://uk.reuters.com/article/brief-beigene-and-mirati-therapeutics-an/brief-beigene-and-mirati-therapeutics-announce-exclusive-license-agreement-for-sitravatinib-in-the-asia-pacific-region-idUKFWN1P30HN

Amplyx Pharmaceuticals Announces Appointment of CFO and Presentation at the JP Morgan 36th Annual Healthcare …

Amplyx Pharmaceuticals Announces Appointment of CFO and Presentation at the JP Morgan 36th Annual Healthcare …  Markets InsiderFull coverage http://markets.businessinsider.com/news/stocks/Amplyx-Pharmaceuticals-Announces-Appointment-of-CFO-and-Presentation-at-the-J-P-Morgan-36th-Annual-Healthcare-Conference-1012663034

Neurocrine Biosciences Announces Retirement of Christopher O’Brien, MD, and Appointment of Eiry W. Roberts, MD …

Neurocrine Biosciences Announces Retirement of Christopher O’Brien, MD, and Appointment of Eiry W. Roberts, MD …  Markets InsiderCan A Similar Series of Events Expected At Neurocrine Biosciences, Inc. (NBIX), Dean Foods Company (DF)  Post AnalystAs Neurocrine Biosciences INC (NBIX) Stock Value Rose, Shareholder Healthcor Management LP Cut Holding by …  BZ WeeklyFull coverage http://markets.businessinsider.com/news/stocks/Neurocrine-Biosciences-Announces-Retirement-of-Christopher-O-Brien-M-D-and-Appointment-of-Eiry-W-Roberts-M-D-as-Chief-Medical-Officer-1012626025

US pharma executives expect deals to pick up after tax overhaul

US pharma executives expect deals to pick up after tax overhaul  ReutersFull coverage https://www.reuters.com/article/us-healthcare-conference-deals/u-s-pharma-executives-expect-deals-to-pick-up-after-tax-overhaul-idUSKBN1EY28E

Create a free website or blog at WordPress.com.

Up ↑

%d bloggers like this: